Fas ligand: a potential target for therapeutic induction of apoptosis and enhancing immunotherapy in cancer

By O'Connell J.  

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 4, 1999-12 ,pp. : 601-611

Informa Healthcare

Access to resources Recommend Favorite

Apoptosis in Cultured Rat Islets of Langerhans and Occurrence of Bcl-2, Bak, Bax, Fas and Fas Ligand

By  

Cells Tissues Organs, Vol. 169, Iss. 2, 2001-05 ,pp. : 113-124

Karger

Access to resources Recommend Favorite

Role of Inducible Nitric Oxide Synthase-Derived Nitric Oxide in Silica-Induced Pulmonary Inflammation and Fibrosis

By Zeidler Patti   Hubbs Ann   Battelli Lori   Castranova Vincent  

Journal of Toxicology and Environmental Health, Vol. 67, Iss. 13, 2004-07 ,pp. : 1001-1026

Taylor & Francis Ltd

Access to resources Recommend Favorite

Targeting the Fas/Fas ligand pathway in cancer

By O’Brien Darren I   Nally Ken   Kelly Raymond G   O’Connor Terrence M   Shanahan Fergus   O’Connell Joe  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 5, 2005-10 ,pp. : 1031-1044

Informa Healthcare

Access to resources Recommend Favorite

Inhibitory effect of M50054, a novel inhibitor of apoptosis, on anti-Fas-antibody-induced hepatitis and chemotherapy-induced alopecia

By Tsuda T.   Ohmori Y.   Muramatsu H.   Hosaka Y.   Takiguchi K.   Saitoh F.   Kato K.   Nakayama K.   Nakamura N.   Nagata S.   Mochizuki H.  

European Journal of Pharmacology, Vol. 433, Iss. 1, 2001-12 ,pp. : 37-45

Elsevier

Access to resources Recommend Favorite